Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Data from second positive pivotal study of PSD502 for treatment of PE presented

At the annual meeting of the Sexual Medicine Society of North America (SMSNA), Inc. in San Diego, Sciele Pharma, Inc., a Shionogi Company and Plethora Solutions Limited, a wholly owned subsidiary of Plethora Solutions Holdings PLC ("Plethora")., today presented data from its second positive pivotal study of PSD502 for the treatment of premature ejaculation (PE).

20 Nov 2009

American Diabetes Association launches redesigned diabetes website

To meet the changing needs of people affected by this growing epidemic, the American Diabetes Association has launched a completely redesigned www.diabetes.org in English and Spanish. Even though diabetes is a growing epidemic, a recent survey conducted by the Association showed that Americans received a failing grade in diabetes awareness.

19 Nov 2009

Positive results from Echo Therapeutics' Symphony tCGM System study

Echo Therapeutics, Inc., a company developing its needle-free Symphony(TM) tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude(TM) SkinPrep System for transdermal drug delivery, today announced positive results of a clinical study of its Symphony tCGM System in patients with Type 1 and Type 2 Diabetes.

19 Nov 2009

Positive results from Sciele Pharma's second pivotal study of PSD502 for the treatment of PE

At the annual meeting of the Sexual Medicine Society of North America, Inc. in San Diego, Sciele Pharma, Inc., a Shionogi Company, and Plethora Solutions Limited, a wholly owned subsidiary of Plethora Solutions Holdings PLC, today presented data from its second positive pivotal study of PSD502 for the treatment of premature ejaculation (PE).

19 Nov 2009

Positive results from REVIVE, a phase 3 pivotal study of avanafil announced

VIVUS, Inc. today announced positive results from REVIVE (TA-301), a phase 3 pivotal study evaluating the safety and efficacy of avanafil, an investigational drug candidate for the treatment of erectile dysfunction (ED), in 646 patients.

18 Nov 2009

Drug therapy offers substantial cost savings than angioplasty

Many patients with diabetes should forego angioplasties for heart disease and just take medicine instead, according to a new National Institutes of Health study led by Stanford University School of Medicine researcher Mark Hlatky, MD.

18 Nov 2009

CONTOUR USB meter available for purchase through Walgreens online pharmacy

Bayer's CONTOUR® USB meter, the first blood glucose monitor that connects directly to a PC or MAC -- providing users with instant access to information and trends about their blood sugar levels -- is now available for purchase through Walgreens online pharmacy and will soon also be available online through CVS and Walmart.

18 Nov 2009

Global Alliance for Chronic Diseases announces targets

The Global Alliance for Chronic Diseases (GACD) on Monday outlined plans "to invest tens of millions of dollars in heart and lung disease studies in a battle against a global epidemic of chronic disease," over five years, Reuters reports.

17 Nov 2009

Global Alliance for Chronic Disease to fight against chronic non-communicable diseases

An alliance of institutions collectively managing an estimated 80 percent of all public health research funding worldwide today announced their first targets for concerted action in the fight against "chronic non-communicable diseases" (CNCDs).

17 Nov 2009

deCODE genetics files voluntary petition for relief under Chapter 11 of the United States Bankruptcy Code

deCODE genetics, Inc. (Nasdaq: DCGN) today announced that it has filed a voluntary petition for relief under Chapter 11 of the United States Bankruptcy Code with the United States Bankruptcy Court for the District of Delaware to facilitate the sale of substantially all of its assets. deCODE is continuing to operate its business and manage its properties as a debtor-in-possession pursuant to Sections 1107 and 1108 of the Bankruptcy Code.

17 Nov 2009

Antioxidant found in vegetables can protect cells from damage caused by infection and injury

Scientists at the University of Pennsylvania School of Medicine discovered that a dietary antioxidant found in such vegetables as broccoli and cauliflower protects cells from damage caused by chemicals generated during the body's inflammatory response to infection and injury. The finding has implications for such inflammation-based disorders as cystic fibrosis (CF), diabetes, heart disease, and neurodegeneration.

17 Nov 2009

Addrenex Pharmaceuticals to be acquired by Sciele Pharma

Sciele Pharma, Inc., a U.S.-based group company of Shionogi & Co., Ltd. and Addrenex Pharmaceuticals, Inc., a privately-held U.S. pharmaceutical company specializing in developing drugs that regulate the adrenergic system, today announced that Sciele has agreed to acquire Addrenex.

16 Nov 2009

Interim data from Hollis-Eden Pharmaceuticals' Apoptone Phase I/II clinical trial presented

Hollis-Eden Pharmaceuticals, Inc., today reported preliminary results of its ongoing Phase I/II clinical trial with Apoptone® (HE3235) for hormone-resistant prostate cancer (also called castrate-resistant prostate cancer or CRPC). Presented at the Molecular Targets and Cancer Therapeutics Conference, which is co-sponsored by the AACR, NCI and EORTC, the poster is titled: "Results of preclinical and clinical Phase I/II open-label dose-ranging trial with HE3235, a synthetic adrenal hormone, in Castrate Resistant Prostate Cancer (CRPC)."

16 Nov 2009

Personal CGM improves glucose control for diabetes patients

In acknowledgement of this year’s World Diabetes Day, which calls on all those responsible for diabetes care to understand diabetes and take control, Medtronic, Inc. (NYSE: MDT) highlights the growing body of clinical evidence for Personal Continuous Glucose Monitoring (CGM) in improving glucose control for diabetes patients.

16 Nov 2009

Columbia University Medical Center presents the 2009 Naomi Berrie Awards

Columbia University Medical Center will present the 2009 Naomi Berrie Awards to a nationally recognized diabetes researcher, and a promising young investigator, for their outstanding achievements in diabetes research.

16 Nov 2009

Decreased heart functions associated with fat collection in different body locations: Study

Researchers from Boston University School of Medicine (BUSM) have shown that fat collection in different body locations, such as around the heart and the aorta and within the liver, are associated with certain decreased heart functions. The study, which appears on-line in Obesity, also found that measuring a person's body mass index (BMI) does not reliably predict the amount of undesired fat in and around these vital organs.

13 Nov 2009

Canadians to celebrate World Diabetes Day in recognition of people who live with diabetes

In recognition of the ongoing commitment by millions of Canadians who build awareness of, and live with diabetes, World Diabetes Day will be celebrated on November 14. An official United Nation's World Health Day, World Diabetes Day marks the birthday of Sir Frederick Banting, who, along with Dr. Charles Best, co-discovered insulin in 1921.

13 Nov 2009

Diabetic retinopathy on the rise; dilated eye exam can help prevent vision loss

The incidence of diabetes continues to increase, particularly among adolescents and young adults. The CDC projects the number of diabetic retinopathy cases will double by 2050. On World Diabetes Day, November 14, the American Academy of Ophthalmology (Academy), through its EyeSmart™ campaign, is reminding the public that an annual dilated eye exam can help prevent vision loss in people with diabetes.

13 Nov 2009

New knowledge of basic science may be applied in future medical treatments

How does the developing pancreas in an embryo 'know' which cells are to produce insulin and which cells are to have other assignments? Researchers need to understand this if they want to be able to treat type-1 diabetes with stem cells developed into insulin-producing beta cells. At Lund University scientists have uncovered pioneering new knowledge, and are publishing it in the journal Cell.

13 Nov 2009

RemedyMD launches first nationwide diabetes registry

RemedyMD (www.RemedyMD.com), the leading provider of Patient registry software, today announced the first nationwide Type 2 Diabetes registry to help clinicians and researchers identify which interventions are most appropriate for specific patient populations.

13 Nov 2009

Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Data from second positive pivotal study of PSD502 for treatment of PE presented

American Diabetes Association launches redesigned diabetes website

Positive results from Echo Therapeutics' Symphony tCGM System study

Positive results from Sciele Pharma's second pivotal study of PSD502 for the treatment of PE

Positive results from REVIVE, a phase 3 pivotal study of avanafil announced

Drug therapy offers substantial cost savings than angioplasty

CONTOUR USB meter available for purchase through Walgreens online pharmacy

Global Alliance for Chronic Diseases announces targets

Global Alliance for Chronic Disease to fight against chronic non-communicable diseases

deCODE genetics files voluntary petition for relief under Chapter 11 of the United States Bankruptcy Code

Antioxidant found in vegetables can protect cells from damage caused by infection and injury

Addrenex Pharmaceuticals to be acquired by Sciele Pharma

Interim data from Hollis-Eden Pharmaceuticals' Apoptone Phase I/II clinical trial presented

Personal CGM improves glucose control for diabetes patients

Columbia University Medical Center presents the 2009 Naomi Berrie Awards

Decreased heart functions associated with fat collection in different body locations: Study

Canadians to celebrate World Diabetes Day in recognition of people who live with diabetes

Diabetic retinopathy on the rise; dilated eye exam can help prevent vision loss

New knowledge of basic science may be applied in future medical treatments

RemedyMD launches first nationwide diabetes registry

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in